Dexcom, fresh from celebrating gaining a CE Mark for its G7 sensor, has also announced another new product, Dexcom ONE. This is expected to be on prescription via the NHS England in the coming months, demonstrating a huge step forward in access to diabetes technology and improved access to potentially lifesaving technology for people with diabetes. This product is an affordable, accessible and easy-to-use rt-CGM that will enable more people with diabetes to gain greater control over their condition.
Dexcom ONE shares the same innovative sensor and transmitter technology as the Dexcom G6 and is suitable for people with Type 1 or Type 2 diabetes using insulin. It is an easy-to-use real-time CGM (rt-CGM) that will be more affordable and accessible for people with diabetes in the UK.
The Dexcom ONE, a wearable sensor and transmitter, puts people firmly in control of their diabetes. By continuously monitoring glucose levels and sending real-time values wirelessly to a compatible smart device* via the Dexcom ONE mobile app, the technology eliminates the need for painful finger pricking to take blood tests. The app was designed to be user friendly, displaying trend arrows to show the speed and direction glucose levels are heading, making in the moment treatment decisions easier. A range of customisable alerts help users avoid potentially dangerous high or low glucose events.
The Dexcom G6 CGM will continue to be available through existing channels to people who require additional support to manage diabetes, for example people who are hypo unaware, children and those using connected devices.
*For a list of compatible devices, visit www.dexcom.com/en-GB/compatibility
†If your glucose alerts and readings from Dexcom ONE do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
This news comes as the National Institute for Health and Care Excellence (NICE) announced new guidance for adults and children managing Type 1 diabetes, where all Type 1 diabetes children/young people offered CGM ahead of Flash (Abbott’s FreeStyle Libre technology, together with education for both they and their families and/or carers on how to use their device. Also, all Type 1 diabetes adults will be offered a choice of CGM devices.
